Xortx announces rescheduling of special meeting of shareholders

Calgary, alberta, oct. 25, 2023 (globe newswire) -- xortx therapeutics inc. ("xortx" or the “company”) (nasdaq: xrtx | tsxv: xrtx | frankfurt: anu), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces that the special meeting of shareholders that was scheduled for 10:00 a.m. (calgary time) on october 25, 2023 (the “meeting”) has been cancelled and will be rescheduled.
XRTX Ratings Summary
XRTX Quant Ranking